Bristol Myers indicates 2026 non-GAAP EPS $6.35 $6.55 while preparing $1.5B $2B Eliquis step back in 2027.
Bristol Myers indicates 2026 non-GAAP EPS $6.35 $6.55 while preparing $1.5B $2B Eliquis step back in 2027.
Want to see every report in real time?
Hundreds of sources worldwide, translated into your language, with alerts for what matters to you.
Sign up free Already have an account? Log in